Trial Profile
Prophylactic vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients: a clinical and pharmacoeconomic study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2006
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 22 Oct 2006 New trial record.